CRNX - Crinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15 revenue of $0.44M misses by $0.28M
- Crinetics Pharmaceuticals press release ( NASDAQ: CRNX ): Q2 GAAP EPS of -$0.81 misses by $0.15 .
- Revenue of $0.44M misses by $0.28M .
- Based on its current plans, the company expects that current cash, cash equivalents and short-term investments will fund its current operating plan into the second half of 2024.
For further details see:
Crinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15, revenue of $0.44M misses by $0.28M